MYR 3.95
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 226.55 Million MYR | -6.46% |
2022 | 242.19 Million MYR | 16.49% |
2021 | 207.91 Million MYR | 30.26% |
2020 | 159.62 Million MYR | -7.05% |
2019 | 171.72 Million MYR | -0.48% |
2018 | 172.55 Million MYR | -3.32% |
2017 | 178.47 Million MYR | 7.28% |
2016 | 166.36 Million MYR | 3.83% |
2015 | 160.23 Million MYR | 10.37% |
2014 | 145.17 Million MYR | -1.49% |
2013 | 147.37 Million MYR | 12.25% |
2012 | 131.29 Million MYR | 3.43% |
2011 | 126.94 Million MYR | 12.5% |
2010 | 112.84 Million MYR | 10.24% |
2009 | 102.35 Million MYR | 13.74% |
2008 | 89.99 Million MYR | 3.82% |
2007 | 86.68 Million MYR | 4.23% |
2006 | 83.16 Million MYR | 20.71% |
2005 | 68.89 Million MYR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q4 | 59.82 Million MYR | 7.06% |
2023 Q3 | 55.87 Million MYR | -2.9% |
2023 FY | 226.55 Million MYR | -6.46% |
2023 Q2 | 57.54 Million MYR | 7.95% |
2023 Q1 | 53.3 Million MYR | -4.46% |
2022 Q1 | 64.75 Million MYR | 32.78% |
2022 Q2 | 62.25 Million MYR | -3.86% |
2022 Q3 | 59.39 Million MYR | -4.59% |
2022 Q4 | 55.8 Million MYR | -6.05% |
2022 FY | 242.19 Million MYR | 16.49% |
2021 Q1 | 51.08 Million MYR | 17.51% |
2021 Q3 | 55.24 Million MYR | 4.6% |
2021 Q4 | 48.76 Million MYR | -11.72% |
2021 FY | 207.91 Million MYR | 30.26% |
2021 Q2 | 52.81 Million MYR | 3.38% |
2020 Q1 | 34.62 Million MYR | -5.81% |
2020 Q3 | 43.34 Million MYR | 13.53% |
2020 FY | 159.62 Million MYR | -7.05% |
2020 Q4 | 43.47 Million MYR | 0.31% |
2020 Q2 | 38.17 Million MYR | 10.26% |
2019 Q4 | 36.76 Million MYR | -20.95% |
2019 FY | 171.72 Million MYR | -0.48% |
2019 Q3 | 46.5 Million MYR | -4.87% |
2019 Q1 | 39.56 Million MYR | -0.59% |
2019 Q2 | 48.88 Million MYR | 23.56% |
2018 Q2 | 45 Million MYR | -4.27% |
2018 FY | 172.55 Million MYR | -3.32% |
2018 Q4 | 39.8 Million MYR | -2.28% |
2018 Q3 | 40.72 Million MYR | -9.5% |
2018 Q1 | 47.01 Million MYR | 6.13% |
2017 Q3 | 44.55 Million MYR | -4.05% |
2017 Q2 | 46.44 Million MYR | 7.56% |
2017 FY | 178.47 Million MYR | 7.28% |
2017 Q1 | 43.17 Million MYR | 2.36% |
2017 Q4 | 44.29 Million MYR | -0.59% |
2016 Q3 | 45.22 Million MYR | 0.33% |
2016 FY | 166.36 Million MYR | 3.83% |
2016 Q4 | 42.18 Million MYR | -6.72% |
2016 Q2 | 45.07 Million MYR | 32.99% |
2016 Q1 | 33.89 Million MYR | -17.04% |
2015 Q2 | 39.33 Million MYR | 4.13% |
2015 Q1 | 37.77 Million MYR | -1.14% |
2015 Q3 | 42.25 Million MYR | 7.42% |
2015 Q4 | 40.85 Million MYR | -3.32% |
2015 FY | 160.23 Million MYR | 10.37% |
2014 Q4 | 38.21 Million MYR | 7.95% |
2014 Q3 | 35.4 Million MYR | -10.12% |
2014 FY | 145.17 Million MYR | -1.49% |
2014 Q2 | 39.38 Million MYR | 22.42% |
2014 Q1 | 32.17 Million MYR | -24.78% |
2013 Q2 | 35.49 Million MYR | 37.15% |
2013 Q3 | 43.22 Million MYR | 21.79% |
2013 Q4 | 42.77 Million MYR | -1.06% |
2013 FY | 147.37 Million MYR | 12.25% |
2013 Q1 | 25.87 Million MYR | -38.05% |
2012 Q3 | 37.55 Million MYR | 31.59% |
2012 FY | 131.29 Million MYR | 3.43% |
2012 Q1 | 23.42 Million MYR | -41.84% |
2012 Q4 | 41.77 Million MYR | 11.24% |
2012 Q2 | 28.53 Million MYR | 21.8% |
2011 Q1 | 27.49 Million MYR | -17.32% |
2011 Q2 | 30.21 Million MYR | 9.89% |
2011 Q4 | 40.28 Million MYR | 39.17% |
2011 FY | 126.94 Million MYR | 12.5% |
2011 Q3 | 28.94 Million MYR | -4.22% |
2010 FY | 112.84 Million MYR | 10.24% |
2010 Q2 | 27.44 Million MYR | 0.0% |
2010 Q3 | 26.74 Million MYR | -2.57% |
2010 Q4 | 33.25 Million MYR | 24.36% |
2009 Q4 | 30.15 Million MYR | 19.8% |
2009 Q3 | 25.17 Million MYR | 0.0% |
2009 FY | 102.35 Million MYR | 13.74% |
2008 FY | 89.99 Million MYR | 3.82% |
2007 FY | 86.68 Million MYR | 4.23% |
2006 FY | 83.16 Million MYR | 20.71% |
2005 FY | 68.89 Million MYR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Duopharma Biotech Berhad | 704.72 Million MYR | 67.852% |